Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	163 Pages	TechNavio	December, 2023	INF18391880

Best Price Guarantee
Price	from $2,500
Length	163 Pages
Publisher	TechNavio
Published Date	December, 2023
SKU	INF18391880

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2024-2028

The phosphoinositide 3-kinase (PI3K) inhibitors market is forecasted to grow by USD 88.18 mn during 2023-2028, accelerating at a CAGR of 5.54% during the forecast period. The report on the phosphoinositide 3-kinase (PI3K) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent approvals of blood therapies, strategic alliances of vendors, and special drug designations for special efficiencies.

Technavio's phosphoinositide 3-kinase (PI3K) inhibitors market is segmented as below:

By Application

CLL
FL
Other indications

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expansion of research indications as one of the prime reasons driving the phosphoinositide 3-kinase (PI3K) inhibitors market growth during the next few years. Also, the rising adoption of reimbursement programs and growing awareness about cancer will lead to sizable demand in the market.

The report on the phosphoinositide 3-kinase (PI3K) inhibitors market covers the following areas:

Phosphoinositide 3-kinase (PI3K) inhibitors market sizing
Phosphoinositide 3-kinase (PI3K) inhibitors market forecast
Phosphoinositide 3-kinase (PI3K) inhibitors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading phosphoinositide 3-kinase (PI3K) inhibitors market vendors that include AbbVie Inc., Bayer AG, Celon Pharma SA, Curis Inc., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Molecular Depot LLC, Novartis AG, TG Therapeutics Inc., Verastem Inc., and Secura Bio Inc.. Also, the phosphoinositide 3-kinase (PI3K) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Application; Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global phosphoinositide 3-kinase (PI3K) inhibitors market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global phosphoinositide 3-kinase (pi3k) inhibitors market 2018 - 2022 ($ million); 4.2 Application Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Exhibit 30: Chart on Application - Market share 2023-2028 (%); Exhibit 31: Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Exhibit 32: Chart on Comparison by Application; Exhibit 33: Data Table on Comparison by Application; 6.3 CLL - Market size and forecast 2023-2028; Exhibit 34: Chart on CLL - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on CLL - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on CLL - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on CLL - Year-over-year growth 2023-2028 (%); 6.4 FL - Market size and forecast 2023-2028; Exhibit 38: Chart on FL - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on FL - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on FL - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on FL - Year-over-year growth 2023-2028 (%); 6.5 Other indications - Market size and forecast 2023-2028; Exhibit 42: Chart on Other indications - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Other indications - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Other indications - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Other indications - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Application; Exhibit 46: Market opportunity by Application ($ million); Exhibit 47: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Distribution Channel: 7.1 Market segments; Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%); 7.2 Comparison by Distribution Channel; Exhibit 50: Chart on Comparison by Distribution Channel; Exhibit 51: Data Table on Comparison by Distribution Channel; 7.3 Hospital pharmacies - Market size and forecast 2023-2028; Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%); 7.4 Retail pharmacies - Market size and forecast 2023-2028; Exhibit 56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); 7.5 Online pharmacies - Market size and forecast 2023-2028; Exhibit 60: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Distribution Channel; Exhibit 64: Market opportunity by Distribution Channel ($ million); Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ million); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million); 10 Drivers, Challenges, and Trends; 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends; 11 Vendor Landscape; 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business; 12 Vendor Analysis; 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 AbbVie Inc.; Exhibit 115: AbbVie Inc. - Overview; Exhibit 116: AbbVie Inc. - Product / Service; Exhibit 117: AbbVie Inc. - Key news; Exhibit 118: AbbVie Inc. - Key offerings; 12.4 Bayer AG; Exhibit 119: Bayer AG - Overview; Exhibit 120: Bayer AG - Business segments; Exhibit 121: Bayer AG - Key news; Exhibit 122: Bayer AG - Key offerings; Exhibit 123: Bayer AG - Segment focus; 12.5 Celon Pharma SA; Exhibit 124: Celon Pharma SA - Overview; Exhibit 125: Celon Pharma SA - Business segments; Exhibit 126: Celon Pharma SA - Key offerings; Exhibit 127: Celon Pharma SA - Segment focus; 12.6 Curis Inc.; Exhibit 128: Curis Inc. - Overview; Exhibit 129: Curis Inc. - Product / Service; Exhibit 130: Curis Inc. - Key offerings; 12.7 Eli Lilly and Co.; Exhibit 131: Eli Lilly and Co. - Overview; Exhibit 132: Eli Lilly and Co. - Product / Service; Exhibit 133: Eli Lilly and Co. - Key news; Exhibit 134: Eli Lilly and Co. - Key offerings; 12.8 Exelixis Inc.; Exhibit 135: Exelixis Inc. - Overview; Exhibit 136: Exelixis Inc. - Product / Service; Exhibit 137: Exelixis Inc. - Key offerings; 12.9 F. Hoffmann La Roche Ltd.; Exhibit 138: F. Hoffmann La Roche Ltd. - Overview; Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 140: F. Hoffmann La Roche Ltd. - Key news; Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus; 12.10 Gilead Sciences Inc.; Exhibit 143: Gilead Sciences Inc. - Overview; Exhibit 144: Gilead Sciences Inc. - Product / Service; Exhibit 145: Gilead Sciences Inc. - Key news; Exhibit 146: Gilead Sciences Inc. - Key offerings; 12.11 Merck KGaA; Exhibit 147: Merck KGaA - Overview; Exhibit 148: Merck KGaA - Business segments; Exhibit 149: Merck KGaA - Key news; Exhibit 150: Merck KGaA - Key offerings; Exhibit 151: Merck KGaA - Segment focus; 12.12 Molecular Depot LLC; Exhibit 152: Molecular Depot LLC - Overview; Exhibit 153: Molecular Depot LLC - Product / Service; Exhibit 154: Molecular Depot LLC - Key offerings; 12.13 Novartis AG; Exhibit 155: Novartis AG - Overview; Exhibit 156: Novartis AG - Business segments; Exhibit 157: Novartis AG - Key offerings; Exhibit 158: Novartis AG - Segment focus; 12.14 Secura Bio Inc.; Exhibit 159: Secura Bio Inc. - Overview; Exhibit 160: Secura Bio Inc. - Product / Service; Exhibit 161: Secura Bio Inc. - Key offerings; 12.15 TG Therapeutics Inc.; Exhibit 162: TG Therapeutics Inc. - Overview; Exhibit 163: TG Therapeutics Inc. - Product / Service; Exhibit 164: TG Therapeutics Inc. - Key offerings; 12.16 Verastem Inc.; Exhibit 165: Verastem Inc. - Overview; Exhibit 166: Verastem Inc. - Product / Service; Exhibit 167: Verastem Inc. - Key offerings; 13 Appendix; 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 168: Inclusions checklist; Exhibit 169: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 170: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 171: Research methodology; Exhibit 172: Validation techniques employed for market sizing; Exhibit 173: Information sources; 13.5 List of abbreviations; Exhibit 174: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global phosphoinositide 3-kinase (pi3k) inhibitors market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Application - Market share 2023-2028 (%); Exhibits31: Data Table on Application - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Application; Exhibits33: Data Table on Comparison by Application; Exhibits34: Chart on CLL - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on CLL - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on CLL - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on CLL - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on FL - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on FL - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on FL - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on FL - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Other indications - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Other indications - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Other indications - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Other indications - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Application ($ million); Exhibits47: Data Table on Market opportunity by Application ($ million); Exhibits48: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits49: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Distribution Channel; Exhibits51: Data Table on Comparison by Distribution Channel; Exhibits52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by Distribution Channel ($ million); Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits107: Market opportunity By Geographical Landscape ($ million); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits109: Impact of drivers and challenges in 2023 and 2028; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: AbbVie Inc. - Overview; Exhibits116: AbbVie Inc. - Product / Service; Exhibits117: AbbVie Inc. - Key news; Exhibits118: AbbVie Inc. - Key offerings; Exhibits119: Bayer AG - Overview; Exhibits120: Bayer AG - Business segments; Exhibits121: Bayer AG - Key news; Exhibits122: Bayer AG - Key offerings; Exhibits123: Bayer AG - Segment focus; Exhibits124: Celon Pharma SA - Overview; Exhibits125: Celon Pharma SA - Business segments; Exhibits126: Celon Pharma SA - Key offerings; Exhibits127: Celon Pharma SA - Segment focus; Exhibits128: Curis Inc. - Overview; Exhibits129: Curis Inc. - Product / Service; Exhibits130: Curis Inc. - Key offerings; Exhibits131: Eli Lilly and Co. - Overview; Exhibits132: Eli Lilly and Co. - Product / Service; Exhibits133: Eli Lilly and Co. - Key news; Exhibits134: Eli Lilly and Co. - Key offerings; Exhibits135: Exelixis Inc. - Overview; Exhibits136: Exelixis Inc. - Product / Service; Exhibits137: Exelixis Inc. - Key offerings; Exhibits138: F. Hoffmann La Roche Ltd. - Overview; Exhibits139: F. Hoffmann La Roche Ltd. - Business segments; Exhibits140: F. Hoffmann La Roche Ltd. - Key news; Exhibits141: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits142: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits143: Gilead Sciences Inc. - Overview; Exhibits144: Gilead Sciences Inc. - Product / Service; Exhibits145: Gilead Sciences Inc. - Key news; Exhibits146: Gilead Sciences Inc. - Key offerings; Exhibits147: Merck KGaA - Overview; Exhibits148: Merck KGaA - Business segments; Exhibits149: Merck KGaA - Key news; Exhibits150: Merck KGaA - Key offerings; Exhibits151: Merck KGaA - Segment focus; Exhibits152: Molecular Depot LLC - Overview; Exhibits153: Molecular Depot LLC - Product / Service; Exhibits154: Molecular Depot LLC - Key offerings; Exhibits155: Novartis AG - Overview; Exhibits156: Novartis AG - Business segments; Exhibits157: Novartis AG - Key offerings; Exhibits158: Novartis AG - Segment focus; Exhibits159: Secura Bio Inc. - Overview; Exhibits160: Secura Bio Inc. - Product / Service; Exhibits161: Secura Bio Inc. - Key offerings; Exhibits162: TG Therapeutics Inc. - Overview; Exhibits163: TG Therapeutics Inc. - Product / Service; Exhibits164: TG Therapeutics Inc. - Key offerings; Exhibits165: Verastem Inc. - Overview; Exhibits166: Verastem Inc. - Product / Service; Exhibits167: Verastem Inc. - Key offerings; Exhibits168: Inclusions checklist; Exhibits169: Exclusions checklist; Exhibits170: Currency conversion rates for US$; Exhibits171: Research methodology; Exhibits172: Validation techniques employed for market sizing; Exhibits173: Information sources; Exhibits174: List of abbreviations